Annual Total Long Term Liabilities
$0.00
-$24.88 M-100.00%
31 December 2023
Summary:
Viracta Therapeutics annual total long term liabilities is currently $0.00, with the most recent change of -$24.88 million (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$5.10 million (-100.00%). VIRX annual total long term liabilities is now -100.00% below its all-time high of $88.22 million, reached on 31 December 2020.VIRX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$0.00
$0.000.00%
30 September 2024
Summary:
Viracta Therapeutics quarterly total long term liabilities is currently $0.00, unchanged on 30 September 2024. Over the past year, it has stayed the same.VIRX quarterly long term liabilities is now -100.00% below its all-time high of $88.22 million, reached on 31 December 2020.VIRX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VIRX Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | 0.0% |
| 3 y3 years | -100.0% | -100.0% |
| 5 y5 years | - | - |
VIRX Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -100.0% | ||
| 5 y | 5 years | -100.0% | -100.0% | ||
| alltime | all time | -100.0% | -100.0% |
Viracta Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $0.00(0.0%) |
| June 2024 | - | $0.00(0.0%) |
| Mar 2024 | - | $0.00(0.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(-100.0%) |
| June 2023 | - | $20.86 M(-9.3%) |
| Mar 2023 | - | $23.01 M(-7.5%) |
| Dec 2022 | $24.88 M | $24.88 M(+397.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $5.00 M(+1.4%) |
| June 2022 | - | $4.93 M(-1.7%) |
| Mar 2022 | - | $5.02 M(-1.6%) |
| Dec 2021 | $5.10 M(-94.2%) | $5.10 M(-5.7%) |
| Sept 2021 | - | $5.40 M(+16.7%) |
| June 2021 | - | $4.63 M(-11.0%) |
| Mar 2021 | - | $5.20 M(-94.1%) |
| Dec 2020 | $88.22 M | $88.22 M |
FAQ
- What is Viracta Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Viracta Therapeutics?
- What is Viracta Therapeutics quarterly long term liabilities year-on-year change?
What is Viracta Therapeutics annual total long term liabilities?
The current annual total long term liabilities of VIRX is $0.00
What is the all time high annual total long term liabilities for Viracta Therapeutics?
Viracta Therapeutics all-time high annual total long term liabilities is $88.22 M
What is Viracta Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of VIRX is $0.00
What is the all time high quarterly long term liabilities for Viracta Therapeutics?
Viracta Therapeutics all-time high quarterly total long term liabilities is $88.22 M
What is Viracta Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, VIRX quarterly total long term liabilities has changed by $0.00 (0.00%)